Recent AML Launches – What Have We Learned?
Recent Launches for Acute Myeloid Leukemia (AML) What We’ve Learned Advancements in medicine have equipped physicians to assign distinct prognostic groups to patients with AML [...]
Recent Posts
Jean-Jacques Borie Appointed Medimix SVP Innovation
Medimix International Expands Its Executive Team Jean-Jacques Borie Joins as …
Medimix Honored for LiveTracker RWD Solution
The crucial importance of Real World Evidence
Health-care is an essential factor in human lives. Every hospital, …
NSCLC Treatment Paradigm: Where Do We Stand?
NSCLC Treatment Paradigm: Where Do We Stand? NSCLC treatment …
Recent AML Launches – What Have We Learned?
Recent Launches for Acute Myeloid Leukemia (AML) What We’ve Learned …